Current status:
Cancelled Post Market
Current status date:
2019-07-17
DIN:
02320045
Electronic product monograph is not available
Route(s) of administration:
Intramuscular
,
Intra-Arterial
,
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
Anatomical Therapeutic Chemical (ATC):
See footnote 4
L01BA01 METHOTREXATE
List of active ingredient(s)
Active ingredient(s) |
Strength |
METHOTREXATE (METHOTREXATE SODIUM)
|
15 MG / 1.5 ML
|